Neuberger Berman High Yield Strategies Fund (NYSEAMERICAN:NHS – Get Free Report) was the target of a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 26,125 shares, a decline of 87.6% from the May 14th total of 209,992 shares. Based on an average trading volume of 258,135 shares, the days-to-cover ratio is presently 0.1 days. Approximately 0.1% of the company’s shares are sold short.
Institutional Trading of Neuberger Berman High Yield Strategies Fund
A number of hedge funds have recently bought and sold shares of the stock. Guggenheim Capital LLC lifted its holdings in shares of Neuberger Berman High Yield Strategies Fund by 38.0% during the 4th quarter. Guggenheim Capital LLC now owns 567,943 shares of the investment management company’s stock worth $4,225,000 after acquiring an additional 156,386 shares during the period. GraniteShares Advisors LLC bought a new position in shares of Neuberger Berman High Yield Strategies Fund during the 4th quarter worth about $2,832,000. Invesco Ltd. lifted its holdings in shares of Neuberger Berman High Yield Strategies Fund by 3.5% during the 2nd quarter. Invesco Ltd. now owns 258,944 shares of the investment management company’s stock worth $1,963,000 after acquiring an additional 8,676 shares during the period. Ameriprise Financial Inc. increased its position in shares of Neuberger Berman High Yield Strategies Fund by 47.4% during the 3rd quarter. Ameriprise Financial Inc. now owns 117,760 shares of the investment management company’s stock worth $883,000 after purchasing an additional 37,860 shares in the last quarter. Finally, Harbour Investments Inc. boosted its position in Neuberger Berman High Yield Strategies Fund by 3.7% in the fourth quarter. Harbour Investments Inc. now owns 109,642 shares of the investment management company’s stock valued at $816,000 after buying an additional 3,930 shares in the last quarter.
Neuberger Berman High Yield Strategies Fund Trading Up 0.5%
Neuberger Berman High Yield Strategies Fund stock opened at $6.33 on Friday. The firm’s 50 day moving average price is $6.41 and its two-hundred day moving average price is $7.00. Neuberger Berman High Yield Strategies Fund has a twelve month low of $6.13 and a twelve month high of $7.75.
Neuberger Berman High Yield Strategies Fund Announces Dividend
About Neuberger Berman High Yield Strategies Fund
The Neuberger Berman High Yield Strategies Fund (NYSE American: NHS) is a closed-end, fixed-income management investment company focused on delivering high current income with the potential for capital appreciation. The fund primarily invests in below-investment-grade corporate debt—often referred to as high-yield bonds—issued by U.S. and select non-U.S. issuers. Through a diversified portfolio of high-yield instruments, NHS aims to provide enhanced yield relative to investment-grade alternatives.
Under its investment policy, NHS allocates the majority of its assets to corporate securities spanning sectors such as communications, energy, consumer goods, and industrials.
Recommended Stories
- Five stocks we like better than Neuberger Berman High Yield Strategies Fund
- Applied Digital Is Building a $36 Billion AI Real Estate Empire
- Why Oracle’s 10% Drop May Be Telling the Wrong Story
- Build On a Strong Earnings Season With These 3 ETFs
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
Receive News & Ratings for Neuberger Berman High Yield Strategies Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neuberger Berman High Yield Strategies Fund and related companies with MarketBeat.com's FREE daily email newsletter.
